Bot Detector
By the
International Journal of Pharmaceutical Compounding
User Name:
Password:
Forgotten Username/Password?
Formulas
Databases
Discontinued
Medications
King Guide to
Parenteral
Admixtures
Standard Operating
Procedures
Universal Claim
Form
Unapproved Drugs
List
USP Compliance
Compounders'
Network List
IJPC Products
Books
Compliance Issues
Education
Newsletter
Compounders'
Resource Directory
About Us
*Disclaimer
Free Trial
Subscribe
Newsletter
Archives of Science and Technology for the Hospital Pharmacist
Newsletter
Subject
Vol. 6 No. 4
Sterility Testing
Vol. 6 No. 3
3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Vol. 6 No. 2
3D Printing: Pharmacy Applications, Part 2: Technologies
Vol. 6 No. 1
3D Printing: Pharmacy Applications, Part 1: Introduction and Applications
Vol. 5 No. 6
Mixing Solids: Random vs Ordered Mixing, Part II
Vol. 5 No. 5
Mixing Solids: Random vs Ordered Mixing, Part I
Vol. 5 No. 4
Blending/Mixing in Liquids in Compounding Dosage Forms
Vol. 5 No. 3
Blending/Mixing of Solids in Liquids in Compounding Dosage Forms
Vol. 5 No. 2
Particle Size Evaluation
Vol. 5 No. 1
Blending/Mixing of Solid Dosage Forms
Vol. 4 No. 10
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Vol. 4 No. 9
Redispensing Compounded and Repackaged Medications within a Health System
Vol. 4 No. 8
Use of Expired Medications During Drug Product Shortages
Vol. 4 No. 7
Does Your Drug Expertise Include Clinical Pharmaceutics?
Vol. 4 No. 6
Method Validation
Vol. 4 No. 5
Cold Reconstitution of Unstable Drugs
Vol. 4 No. 4
Stability-indicating Assays
Vol. 4 No. 3
QUALITY CONTROL: Refractive Index IV: Implementation
Vol. 4 No. 2
QUALITY CONTROL: Refractive Index III: Controlled Drug Substances
Vol. 3 No 12
QUALITY CONTROL: Refractive Index II: Osmolarity
Vol. 3 No. 11
QUALITY CONTROL: Refractive Index I: Parenteral Nutrition Solution
Vol. 4 No. 1
3% Sodium Intravenous Infusion
Vol. 3 No. 10
What's in a Nonproprietary Drug (Generic) Name?
Vol. 3 No. 9
The Biopharmaceutics Classification System and Compounding Pharmacy, Part II
Vol. 3 No. 8
The Biopharmaceutics Classification System and Compounding Pharmacy, Part I
Vol. 3 No. 7
Calculating the Endotoxin Load in Compounded Sterile Preparations
Vol. 3 No. 6
Application of United States Pharmacopeia Monographs to Manufacturing and Compounding
Vol. 3 No. 5
Role of the United States Pharmacopeia in Pharmacy Practice
Vol. 3 No. 4
An Overview of United States Pharmacopeia Sterility Testing
Vol. 3 No. 3
Potency and Stability Testing
Vol. 3 No. 2
What Kind of Drugs Are You Dispensing or Selling?
Vol. 3 No. 1
End-preparation Assessments and Tests for Compounded Sterile Preparations
Vol. 2 No. 11
Pros and Cons of Using Bulk Chemicals to Compound
Vol. 2 No. 10
Hazardous Compounding in Health Systems
Vol. 2 No. 9
It is NOT Just About Sterile Compounding! OR What About Nonsterile Compounding?
Vol. 2 No. 8
How It All Gets Absorbed
Vol. 2 No. 7
Basics of Compounding With Organic Salts
Vol. 2 No. 6
Unit-dose Packaging
Vol. 2 No. 5
Beyond-use Date: Establishment and Maintenance
Vol. 2 No. 4
Compounding with Commercial Drug Products Can Cause Errors!
Vol. 2 No. 3
Compounding Information Resources
Vol. 2 No. 2
General Guidelines/Summary for Compatibility (Solubility) and Chemical Stability
Vol. 2 No. 1
The
ps
in Thera
p
eutic
s
Vol. 1 No. 8
pH and Solubility, Stability, and Absorption, Part II
Vol. 1 No. 7
pH and Solubility, Stability, and Absorption, Part I
Vol. 1 No. 6
Packaging/Container Issues: Unit-dose, Pre-filled Syringes, Pre-packs, Etc.
Vol. 1 No. 5
Potential Problems in Compounding for Pediatric Patients
Vol. 1 No. 4
Documentation of Potential Problems in Compounding with Manufactured Products
Vol. 1 No. 3
Beyond-Use Dates, Part 3
Vol. 1 No. 2
Beyond-Use Dates, Part 2
Vol. 1 No. 1
Beyond-Use Dates, Part 1